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Aims of study. The aim of the present study was to investigate whether an ethanol extract of Scutellaria baicalensis (ESB) relaxes
penile corpus cavernosum muscle in organ bath experiments. Materials and methods. Changes in tension of cavernous smooth
muscle strips were determined by penile strip chamber model and in penile perfusion model. Isolated endothelium-intact
rabbit corpus cavernosum was precontracted with phenylephrine (PE) and then treated with ESB. Results. ESB relaxed penile
smooth muscle in a dose-dependent manner, and this was inhibited by pre-treatment with NG-nitro-l-arginine methyl ester (l-
NAME), a nitric oxide (NO) synthase inhibitor, and 1H-[1, 2, 4]-oxadiazolo-[4,3-α]-quinoxalin-1-one (ODQ), a soluble guanylyl
cyclase (sGC) inhibitor. ESB-induced relaxation was signiﬁcantly attenuated by pretreatment with tetraethylammonium (TEA), a
nonselective K+ channel blocker, and charybdotoxin, a selective Ca2+-dependent K+ channel inhibitor. ESB increased the cGMP
levelsofrabbitcorpuscavernosuminaconcentration-dependentmannerwithoutchangesincAMPlevels.Inaperfusionmodelof
penile tissue, ESB also relaxed penile corpus cavernosum smooth muscle in a dose-dependent manner. Conclusion.T a k e nt o g e t h e r ,
these results suggest that ESB relaxed rabbit cavernous smooth muscle via the NO/cGMP system and Ca2+-sensitive K+ channels
in the corpus cavernosum.
1.Introduction
Penile erection is a hemodynamic process induced by both
increased arterial inﬂow and restricted venous outﬂow and is
coordinated with smooth muscle relaxation within the cor-
pus cavernosum under neural control [1, 2]. Penile tumes-
cence and detumescence are regulated by a complex neuro-
physiological process involving the relaxation and contrac-
tion, respectively, of the corpus cavernosum. Erection occurs
when the penile arteries and corpus cavernosal smooth mus-
cle are relaxed by nitric oxide (NO) released from nerve end-
ings and endothelial cells [3, 4]. The activation of the soluble
guanylyl cyclase (sGC) by NO results in an increase of
intracellular cGMP production which stimulates the cGMP-
dependent protein kinase (PKG) that, in turn, lowers in-
tracellular Ca2+ concentrations and/or the Ca2+ sensitivity
of the contractile machinery to produce relaxation [5]. In
penile tissue, cGMP is predominantly metabolized by phos-
phodiesterasetype5(PDE5).Thisenzymeisthemostprom-
inent target of the NO/cGMP signalling cascade identiﬁed
to date for pharmacological intervention in erectile dysfunc-
tion. Therefore, the NO/cGMP pathway plays a key role in
penile erection.
Penile erection is a result of increased intracavernous
blood ﬂow and pressure (ICP). Thus, pharmacologically ac-
tive agents that are capable of increasing the blood ﬂow and
pressure can also ameliorate erectile dysfunction (ED). An-
other candidate for the treatment of ED is the K+ channel
activator. The large conductance Ca2+-sensitive K+ (BKCa)
channels,ATP-sensitivepotassium(KATP)channels,andvolt-
age-activated K+ (KV) channels are important modulators of
cavernous smooth muscle tone.2 Evidence-Based Complementary and Alternative Medicine
Recently, in the course of searching for potential ther-
apeutic agents from traditional oriental medicines for the
treatment of ED, we found that extracts of Scutellaria baical-
ensis Georgi (Hwang Geum in Korea; Huang Qin in China)
elicit cavernous smooth muscle relaxation. The dried root of
S. baicalensis (Solanaceae) is an important traditional med-
icine widely used in China, Korea, and Japan because of its
therapeutic eﬀectiveness in the treatment of dysentery, pyr-
exia, jaundice, and carbuncles [6, 7]. It is known to have a
multitude of pharmacological eﬀects, including anti inﬂam-
matory [8], antidiabetic [9], antiviral [10], antihypertension
[6], antioxidant [8, 11, 12], and anticancer [13]e ﬀects. The
roots are rich in baicalein, baicalin, wogonin, chrysin, and
wogonoside, which exert anti-inﬂammatory and antioxidant
activities. Baicalein induces relaxation in rat mesenteric ar-
tery [14]. Moreover, baicalein and wogonin inhibit collagen
deposition [15]. In addition, studies have reported that long-
term baicalein administration ameliorates metabolic disor-
der [16]. However, to the best of our knowledge, the eﬀect of
S. baicalensis on ED has not yet been deﬁned. Therefore, the
purpose of the present study was to investigate the cavernous
smooth muscle relaxant activity of an ethanol extract of the
root of S. baicalensis (ESB) and its mechanism of action.
Moreover, this study was designed to investigate the eﬀect
of ESB on erectile function and to explore the association of
NO/cGMP pathway in rabbit corpus cavernosum.
2.MaterialsandMethods
2.1. Extraction of S. baicalensis. The root of S. baicalensis
(Solanaceae) was purchased from the Herbal Medicine Co-
operative Association Iksan, Korea in July 2008. Herbarium
voucher specimens of ESB (DH-127) were prepared and
deposited in the Herbarium of the Professional Graduate
School of Oriental Medicine, Wonkwang University, Iksan,
Korea. The dried root of S. baicalensis (600g) was extracted
in 3L of ethanol (99%) at 24◦C for 7 days, ﬁltered through
Whatman No. 2 ﬁlter paper, and concentrated using a rotary
evaporator. After lyophilized using freeze-drier, the yield of
the ethanol extract (ESB) was 2.02% of the plant powder and
dissolved in dimethyl sulfoxide (DMSO). The ﬁnal concen-
tration of DMSO was less than 0.1%.
2.2.High-PerformanceLiquidChromatographyFingerprinting
and Nuclear Magnetic Resonance Analysis. A portion of the
extract(2.3g)wassubjectedtooctadecylfunctionalizedsilica
gelﬂashcolumn(5×40cm;particlesize,75μm)chromatog-
raphy. The column was eluted with a stepwise gradient of
methanol (MeOH) in H2O (from 20% to 100% with 20%
increments; 5 fractions of 500mL each), followed by 500mL
of 50% MeOH in CH2Cl2, resulting in the collection of 6
fractions (Fr. 1–6). A portion of the fraction that was eluted
with40%MeOHinH2Owasfurtherpuriﬁedbysemiprepar-
ative reversed-phase high-performance liquid chromatogra-
phy (HPLC; Agilent prep-C18 column [21.2 × 150mm; par-
ticle size, 5 μm]; 5mL/min; detection wavelength, 254nm)
by eluting with a gradient of 30–58% MeOH in H2O (0.1%
formicacid)over16mintoyield1(tR =18.3min).Aportion
of the fraction that eluted with 80% MeOH in H2Ow a s
further puriﬁed by semipreparative reversed-phase HPLC
using an identical column, but eluting with a gradient of 60–
73% MeOH in H2O (0.1% formic acid) over 25min to yield
2 (tR = 19.4min), 3 (tR = 20.5min), and 4 (tR = 25.0min).
Nuclear magnetic resonance (NMR) spectra (1D and 2D)
were recorded using a JEOL JNM ECP-400 spectrometer
(400MHz for 1H and 100MHz for 13C), and chemical shifts
werereferencedrelativetothecorrespondingresidualsolvent
signals. Heteronuclear single-quantum coherence (HSQC)
and heteronuclear multiple bond coherence (HMBC) exper-
iments were optimized for 1JCH = 140Hz and nJCH = 8Hz,
respectively. The chromatographic ﬁngerprint of the ethanol
extract of S. baicalensis was performed on a YOUNGLIN
system (YOUNGLIN Instrument, Korea) equipped with a
YOUNGLIN UV detector (UV 730D) and Zam3000 Evap-
orative Light Scattering Detector (Schambeck SFD GmbH,
Bad Honnef, Germany). Chromatographic separation was
carried out on an Eclipse XDB-C18 column (4.6mm ×
150mm; particle size, 5μm) at room temperature with an
injection volume of 50μL using a gradient elution of 10%
MeOH in water (0.1% formic acid) to 100% MeOH over
60min. Peaks were detected simultaneously at both 210 and
254nm by UV detection.
2.3.OrganBathExperiments. Theanimalprocedureswerein
strict accordance with the National Institute of Health Guide
for the Care and Use of Laboratory Animals and were ap-
provedbytheInstitutionalAnimalCareandUtilizationcom-
mittee for Medical Science of Wonkwang University. Adult
(4-5-month-old) male New Zealand White rabbits (3.0–
3.5kg) were sacriﬁced by an overdose of pentobarbitone in-
jected into the marginal vein of the ear. The corpus caver-
nosum strips were mounted in tissue baths containing 5mL
Krebs solution (118mM NaCl, 4.7mM KCl, 1.1mM MgSO4,
1.2mM KH2PO4,1 . 5 m MC a C l 2,2 5 m MN a H C O 3,a n d
10mM glucose) at 37◦C equilibrated in 95% O2 and 5%
CO2. The strips were suspended with silk ties to a force-
displacementtransducer(GrassFT03;GrassInstrumentCo.,
Quincy, Mass, USA), and isometric tension was recorded on
the physiograph. After a 60-min equilibration, the strips of
corpus cavernosum were loaded with a resting tension of 1g
and then contracted with 1μM phenylephrine (PE) to obtain
stable peak response. Once stable peak response to PE had
been obtained, the cavernosal strips were exposed to cumu-
lative doses of the testing agent, and the responses were re-
corded. To deﬁne the mechanisms by which ESB relaxes cav-
ernosal strips, the strips were exposed to various modulating
agents (indomethacin, diltiazem, atropine, propranolol, etc.)
for 20min, and then cavernosal smooth muscle relaxation
was carried out by cumulative addition of ESB. The eﬀect of
vehicle, <0.1% dimethylsulfoxide (DMSO), was also tested.
Aftereachtest,thecavernosalstripswerewashed3timeswith
fresh Krebs solution and allowed to equilibrate for 30min.
2.4. Measurement of cGMP and cAMP Levels in Corpus Caver-
nosum. To determine the eﬀect of ESB on cGMP and cAMP
levels, we used healthy male rabbit corpus cavernosum. AfterEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Chemical structures of compounds 1–4(a) and an HPLC
chromatographic proﬁle of the extract of S. baicalensis (b). The
identity of the compounds was conﬁrmed by coelution with au-
thentic samples.
equilibration of the cavernosal strips for 60min in 2mL of
Krebs solution gassed with 95% O2/5% CO2 at a constant
temperature of 37◦C in a shaking water bath, the strips were
incubatedfor anadditional 20min in the presence of 100μM
3-isobutyl-1-methylxanthine (IBMX) before the addition of
1μM PE. After the cavernosal strips were subjected to ESB
in the presence or absence of modulators for 5min, the re-
actions were stopped by freezing the tissues in liquid N2.
The tissues were homogenized with a polytron homogenizer
in 500μL of 6% trichloroacetic acid (TCA) solution. The
homogenateswere centrifugedat 13,000rpm for15min, and
the supernatants were collected. The protein concentration
wasdeterminedbythemethodofBradford(Bradford,1976).
The supernatant was extracted 3 times with water-saturated
diethylether and concentrated using a Speed-Vac concentra-
tor (Savant Instrument, Farmingdale, NY, USA). cGMP and
cAMP content was measured by an equilibrated radioim-
munoassay by using a method as previously described [17].
In brief, standards or samples were introduced in a ﬁnal vol-
ume of 100μLo f5 0m Ms o d i u ma c e t a t eb u ﬀer (pH 4.85).
Then, 100μL each diluted cGMP or cAMP antiserum (Cal-
biochem-Novabiochem Co., San Diego, Calif, USA) and
iodinated cGMP or cAMP (10,000cpm/100μL) were added
−log[ESB] (g/mL)
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Figure 2: Eﬀects of ESB on PE-precontracted endothelium-intact
cavernosal smooth muscle strips. The vehicle treatment was 0.1%
DMSO. Mean values ± S.E. (n = 7) are shown.
in succession and incubated for 24h at 4◦C, respectively. The
bound form was separated from the free form by charcoal
suspension. Results were expressed as picomoles of cGMP
and cAMP per milligram of protein per minute.
2.5. Measurement of Isometric Tension in Perfused Penile Tis-
sueModel. NewZealandWhiterabbitsweighing(3.0–3.5kg)
were used. Rabbits were anesthetized by injecting ketamine-
HCl(50mg/kg).Wholepeniswasincisedfromhipbonewith
extreme care to protect the endothelium from inadvertent
damage. Dissected penis carefully moved to oxygenated sa-
line and separate penis muscle from urethra. The perfused
penis model was as follows [18]. Two small cannulas were
buriedproximalcrusofpenisandﬁxed.Theendofglanswas
cut to make the perfusate ﬂow out. The cannulated penis was
placedinatemperature-regulatedorganchamber.Theupper
part of cannula ﬁxed on force transducer (PowerLab/8sp,
ADInstruments, Australia) to record tension. The penis was
perfused with Krebs buﬀer solution by means of a peristaltic
pump (0.25mL/min). The composition of the buﬀer was as
follows (in mM): 118 NaCl, 4.7 KCl, 2.5 CaCl2,1 .2MgC l 2,2 5
NaHCO3, 10.0 glucose (adjust to pH 7.4), and 0.1% bovine
serum albumin (BSA). The temperature of organ bath was
maintained with circulator at 37◦C. The perfusate was pre-
warmed to 37◦C by passage through a water bath and equi-
librated with oxygen by passage through silicone tubing in a
gas mixing chamber. After stabilization for 2 hour, the penis4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: (a) Eﬀects of 0.1mM l-NAME and 10μM ODQ on ESB-induced relaxation of rabbit cavernosal smooth muscle strips. (c), (d)
Eﬀects of ESB on cGMP and cAMP level in crude homogenates of rabbit corpus cavernosum tissues. (b) Eﬀects of l-NAME and ODQ on
the ESB-induced increase of cGMP levels in crude homogenates of rabbit corpus cavernosum tissues. Mean values ± S.E. (n = 5) are shown.
∗P<0.01, ∗∗P<0.001 versus vehicle, #P<0.001 versus ESB.
was perfused for 60min and collected at 2min intervals for
analyses.
2.6. Reagents. Sodium chloride, potassium chloride, calcium
chloride, magnesium chloride, sodium bicarbonate, glu-
cose, bovine serum albumin, sodium acetate, theophylline,
sodium azide, potassium phosphate monobasic, potassium
phosphate dibasic, phenyl mercuric acetate, charcoal, acetyl-
choline chloride (ACh), phenylephrine HCl (PE), NG-nitro-
L-arginine methyl ester (l-NAME), 1H-[1, 2, 4]-oxadiazole-
[4,3-α]-quinoxalin-1-one (ODQ), indomethacin, gliben-
clamide, tetraethylammonium chloride (TEA), 3-isobutyl-
1-methyl-xanthine (IBMX), atropine, and (±)-propranolol
HCl were purchased from Sigma Chemical Co (St. Louis,Evidence-Based Complementary and Alternative Medicine 5
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Figure 4: (a) Comparison of ESB-induced cavernous smooth muscle relaxation in high K-contracted and PE-precontracted rabbit
cavernosum smooth muscle strips. The mean value ± S.E. are shown. KCl 45mM (n = 5), KCl + ESB (n = 5), PE + ESB (n = 7). ∗P<0.001
versusPE+ESB.(b)EﬀectsofK+ channelblockadeonESB-inducedrabbitcavernoussmoothmusclerelaxation.TEA,tetraethylammonium;
gliben, glibenclamide. (c) Eﬀect of K+-selective inhibitor on ESB-induced rabbit cavernous smooth muscle relaxation. Mean values ± S.E.
(n = 5) is shown. ∗P<0.001 versus vehicle. (d) Eﬀect of 4-aminopyridine (4-AP) on ESB-induced rabbit cavernous smooth muscle
relaxation. Mean values ± S.E. (n = 4) are shown.6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Eﬀect of 10μM diltiazem on ESB-induced relaxation in
PE-precontracted cavernosal smooth muscle strips. Mean values ±
S.E. (n = 4) are shown.
Mo,USA),and4-aminopyridine(4-AP)waspurchasedfrom
Biomol (Plymouth Meeting, Pa, USA). The following ref-
erence materials were obtained from the sources speciﬁed:
anti-cGMP and anti-cAMP (Merck Bioscience Calbiochem,
USA)and 125I-Na(AmershamBiosciences,Sweden).Control
experimentsdemonstratedthattheconcentrationofdimeth-
yl sulfoxide (DMSO, 0.1%) had no signiﬁcant eﬀect on cav-
ernous smooth muscle tone.
2.7. Statistical Analyses. Relaxant responses are expressed as
percentage relaxation of the PE precontraction levels unless
otherwise described in the ﬁgure legends. Results were ex-
pressed as mean ± S.E. The statistical signiﬁcance of diﬀer-
ence between the group means was determined using one-
way analysis of variance (ANOVA) and Student’s t-test.
3. Results
3.1. Identiﬁcation of Compounds in Extracts of S. baicalensis.
The structures of compounds 1–4 were identiﬁed as (2R,
3R)-2 ,3,5,6 ,7-pentahydroxyﬂavanone [19], baicalein [20],
neobaicalein[21],andwogonin[20],respectively,byanalysis
of 1D- and 2D-NMR data and comparisons with reported
molecules (Figure 1(a)). The presence and identiﬁcation
of (2R, 3R)-2 ,3,5,6 ,7-pentahydroxyﬂavanone (1), baicalein
(2), neobaicalein (3), and wogonin (4) in the extract of S.
baicalensis was conﬁrmed by cochromatography with their
respective isolated compounds on HPLC (Figure 1(b)).
3.2. Eﬀects of ESB Extracts on the Cavernous Smooth Muscle
Tone of Rabbit. ESB relaxed the PE-precontracted endothe-
lium-intact cavernous smooth muscle strip preparation in
a dose-dependent manner (Figure 2). The maximal relaxant
eﬀect of ESB, achieved at a concentration of 0.3mg/mL, was
89.85 ± 9.97% (Figure 2). DMSO (0.1%), a vehicle for ESB,
had no signiﬁcant relaxant eﬀect.
3.3. Eﬀect of NO Synthase Inhibition on ESB-Induced Cav-
ernous Smooth Muscle Relaxation. The eﬀect of NO on ESB-
induced cavernous smooth muscle relaxation was tested
using l-NAME, an inhibitor of NO synthase. The addition
of 0.1mM l-NAME to the cavernous smooth muscle prepa-
ration signiﬁcantly attenuated the ESB-induced relaxation
eﬀect (Figure 3(a)). This ﬁnding indicates that ESB elicits
cavernous smooth muscle relaxation via NO-dependent sig-
nalling.
3.4. Eﬀect of Inhibition of Guanylyl Cyclase Activity on ESB-
Induced Cavernous Smooth Muscle Relaxation. To further
verify the involvement of cGMP in EBS-induced cavernous
smooth musclerelaxation,wetestedtheeﬀectofODQ,asol-
uble guanylyl cyclase (sGC) inhibitor. The addition of 10μM
ODQ signiﬁcantly attenuated the ESB-induced cavernous
smooth muscle relaxation (Figure 3(a)), indicating that ESB
induces cavernous smooth muscle relaxation via sGC-cGMP
signalling.
3.5. Eﬀect of ESB on the Levels of cGMP and cAMP in Crude
Tissue Homogenates of Rabbit Corpus Cavernosum. Incuba-
tion of corpus cavernosum strips with ESB increased the lev-
els of cGMP in a concentration-dependent manner (Figure
3(b)).Theadditionof l-NAMEandODQtothecorpuscav-
ernosumstrippreparationblockedtheESB-inducedincrease
of cGMP levels (Figure 3(c)). On the other hand, ESB had no
eﬀect on the cAMP levels of the corpus cavernosum smooth
muscle (Figure 3(d)), indicating that ESB induces cavernous
smooth muscle relaxation via NO-sGC-cGMP signalling.
3.6. Eﬀects of K+ Channel Inhibitors on ESB-Induced Cav-
ernous Smooth Muscle Relaxation. ESB caused a concentra-
tion-dependent relaxation of PE-precontracted cavernous
smooth muscle. However, the relaxant eﬀect of ESB was
greatly reduced in the presence of high K+ (45mM) com-
paring with the presence of PE (P<0.001, Figure 4(a)). To
verify the involvement of K+ channels on ESB-induced cav-
ernous smooth muscle relaxation, we treated a endothelium-
intact cavernous smooth muscle strip with 1mM TEA, a
nonselective inhibitor of K+ channel blocker; 10μMg l i b e n -
clamide, an adenosine triphosphate (ATP)-sensitive K+
(KATP) channel blocker; 0.01μM charybdotoxin, a Ca2+-de-
pendent K+ channel blocker; 100μM 4-AP, a voltage-de-
pendentK+ channelblocker.ESB-inducedcavernoussmooth
muscle strip relaxation was signiﬁcantly attenuated by TEA
and charybdotoxin, but not by 4-AP or glibenclamide
(Figures 4(b), 4(c),a n d4(d)). These ﬁndings suggest that
ESB elicits cavernous smooth muscle relaxation via K+ chan-
nels, particularly the KCa channels.Evidence-Based Complementary and Alternative Medicine 7
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Figure 6: Eﬀect of 10μM indomethacin, 1μM atropine, and 1μM propranolol on ESB-induced relaxation in PE-precontracted rabbit
cavernosal smooth muscle strips. Mean values ± S.E. (n = 4) are shown.
3.7. Eﬀects of Ca2+ on ESB-Induced Cavernous Smooth Muscle
Relaxation. To verify the involvement of Ca2+ channels on
ESB-induced cavernous smooth muscle strip relaxation, we
treated a smooth muscle strip with 10μM diltiazem, a volt-
age-gated Ca2+ channel blocker. Diltiazem had no eﬀect on
ESB-induced cavernous smooth muscle relaxation (Figure
5).
3.8. Eﬀects of Prostacyclin on ESB-Induced Cavernous Smooth
Muscle Relaxation. To verify the involvement of prostacyclin
(PGI2) on ESB-induced cavernous smooth muscle strip re-
laxation, we tested the eﬀect of indomethacin, a nonspeciﬁc
cyclooxygenase inhibitor. The relaxant eﬀect of ESB on cav-
ernous smooth muscle was not signiﬁcantly inﬂuenced by
pretreatment with 10μM indomethacin (Figure 6(a)). This
ﬁnding suggested that cyclooxygenase products were not
involved in the ESB-induced relaxation of cavernous smooth
muscle.
3.9.EﬀectsofInhibitorsofAdrenergicandMuscarinicReceptors
on ESB-Induced Cavernous Smooth Muscle Relaxation. To
verify the involvement of adrenergic and muscarinic recep-
tors in ESB-induced cavernous smooth muscle strip relax-
ation, we tested the eﬀects of atropine, an inhibitor of mus-
carinic receptors, or propranolol, a nonselective blocker of
β-adrenoreceptors, on a smooth muscle strip. Pretreatment
of the smooth muscle strip with 1μM atropine or 1μMp r o -
pranolol had no eﬀect on ESB-induced cavernous smooth
muscle relaxation (Figure 6(b)). These ﬁndings indicate that
adrenergicandmuscarinicreceptorsarenotinvolvedinESB-
induced cavernous smooth muscle relaxation.
3.10.EﬀectsofESBonMuscleTensioninPerfusedRabbitPenile
Tissue. Penile corpus cavernosum smooth muscle tension
was measured to conﬁrm the relaxant eﬀect of ESB on cav-
ernous smooth muscle in the penile perfusion model. As
shown in Figure 7, sodium nitroprusside (SNP, a NO donor)
and sildenaﬁl (type-5 PDE inhibitor) decreased the penile
tissue tension in penile corpus cavernosum smooth muscle
with the penile perfusion model in a dose-dependent man-
ner, respectively. ESB also relaxed penile corpus cavernosum
smooth muscle in a dose-dependent manner (Figure 7(c)).
4. Discussion
Nitric oxide, derived from vascular endothelial and neural
sources,playsanessentialroleintheearlystepsofthenormal
cascade of relaxation of the penile vasculature and cavernous
smoothmuscle,anditsactionismediatedthroughthecGMP
system [22, 23]. The present study shows that ESB elicits
the relaxation of PE-precontracted cavernous smooth mus-
cle strips in penile corpus cavernosum smooth muscle with8 Evidence-Based Complementary and Alternative Medicine
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Figure 7: (a) Eﬀect of SNP (a), sildenaﬁl (b), and ESB (c) on corpus cavernosum smooth muscle tension in the perfused rabbit penile tissue.
Each value shows mean ± S.E. (n = 6). ∗P<0.05, ∗∗P<0.01, ∗∗∗P<0.001 versus PE.
penile strip chamber model as well as in penile perfusion
model. The eﬀects of various inhibitors were examined to
verify the mechanism of ESB-induced relaxation. Pretreat-
ment of cavernous smooth muscle with l-NAME, an inhib-
itor of NO synthase, and ODQ, an inhibitor of sGC, atten-
uated ESB-induced cavernous smooth muscle relaxation. In
addition, these inhibitors blocked the ESB-induced increase
of cGMP levels in the rabbit corpus cavernosum. These ﬁnd-
ings suggest that ESB-induced relaxation is closely associated
with the activation of NO/cGMP signalling.
K+ channels also regulate corpus cavernosum smooth
muscle tone [24]. K+ channel opener reduces the tissue ten-
sion or contractile force in response to the relaxation of the
cavernous smooth muscle [25]. Vasodilators depend on the
K+ channel mechanism, reducing their vasorelaxant eﬀects
in response to solutions containing high concentrations of
K+, because an increase in extracellular K+ attenuates the
K+ gradient across the plasma membrane, thereby rendering
the K+-channel-activating mechanism ineﬀective [26].
Therefore, an impairment in K+ channel activity may con-
tribute to erectile dysfunction, and, hence, we further inves-
tigated the possibility of K+ channel activation by ESB. The
importance of K+-channel-mediated hyperpolarization in
response to ESB was demonstrated by the potent diﬀerence
of ESB on KCl-induced contraction compared to PE-in-
duced contractions (P<0.001). The ability of ESB to induce
relaxation was greatly reduced in the presence of high K+
(45mM).TherelaxanteﬀectsofESB,whichweresignificant-
ly reduced by TEA (K+ channel blocker) and charybdotoxin
(Ca2+-dependent K+ channel blocker) [27], further suggest
that the relaxant eﬀects of ESB might be partly associated
with K+ channel activities. However, ESB-induced cavernous
smooth muscle relaxation was not blocked by the addition
of glibenclamide (KATP channel blocker) or 4-AP (voltage-
dependent K+ channel blocker) [28].Evidence-Based Complementary and Alternative Medicine 9
Calcium channels play an essential role in NO synthesis
and release in endothelial cells. NO is known to activate K+
channels, either through the activity of cGMP-dependent
proteinkinase[29]orbydirectopeningofCa2+-activatedK+
channels without the requirement for cGMP [30]. cGMP
is thought to cause the relaxation of smooth muscle by
loweringtheintracellularCa2+ concentration,eitherbystim-
ulating Ca2+-ATPase activity or through opening K+ chan-
nels, leading to hyperpolarization and subsequent reduction
of Ca2+ inﬂux through voltage-operated Ca2+ channels [29,
31]. This study showed that ESB-induced relaxation was not
inhibited by diltiazem (voltage-gated calcium channel block-
er) in cavernous smooth muscle.
Prostacyclin generated by endothelial cells has vasodila-
tory and antiaggregating eﬀects on platelets [32]. To deter-
mine whether prostacyclin is involved in ESB-induced cav-
ernous smooth muscle relaxation, we assayed the eﬀect of
indomethacin, a nonselective cyclooxygenase inhibitor, on
ESB-induced relaxation. Our results show that ESB-induced
cavernous smooth muscle relaxation was not inhibited by
indomethacin, a prostacyclin synthesis blocker. To assess
whetherenhancedNOreleasebyESBwasassociatedwiththe
activation of muscarinic or adrenergic receptors, we exam-
ined the eﬀects of atropine or propranolol on ESB-induced
relaxation. The physiologic regulation of penile tumescence
involves a balance between relaxation and contractile events.
Relaxation is mainly promoted by endothelium-dependent
mechanisms and stimulation of nitrergic nerves. In contrast,
adrenergic neurotransmission has been reported as a pro-
moter of penile ﬂaccidity through the activation of α-adren-
ergic receptors [33]. Preincubation of the cavernous smooth
muscle strips with atropine or propranolol did not aﬀect
ESB-induced relaxation. These ﬁndings indicate that ESB
does not interact with muscarinic or β-adrenergic receptors.
Taken together, our ﬁndings suggest that the major
mechanism underlying the relaxation of penile tissue by ESB
involves the NO/cGMP system and Ca2+-sensitive K+ chan-
nels in the corpus cavernosum.
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